AEye, Inc. Files 8-K: Corporate Updates
Ticker: LIDRW · Form: 8-K · Filed: Jan 23, 2025 · CIK: 1818644
Sentiment: neutral
Topics: corporate-event, filing-update, name-change
TL;DR
AEye, Inc. filed an 8-K on Jan 23, 2025, reporting corporate events and financials; formerly CF Finance Acquisition Corp. III.
AI Summary
AEye, Inc. filed an 8-K on January 23, 2025, reporting on "Other Events" and "Financial Statements and Exhibits." The filing indicates a change in its corporate structure or reporting, as it was formerly known as CF Finance Acquisition Corp. III until July 17, 2020. The company is incorporated in Delaware and its principal executive offices are located in Pleasanton, California.
Why It Matters
This 8-K filing signals routine corporate reporting and potential structural changes for AEye, Inc., which could impact investors' understanding of its current operational status and history.
Risk Assessment
Risk Level: low — This filing appears to be a routine corporate disclosure and does not immediately indicate significant financial distress or major strategic shifts.
Key Players & Entities
- AEye, Inc. (company) — Registrant
- CF Finance Acquisition Corp. III (company) — Former company name
- January 23, 2025 (date) — Date of report
- July 17, 2020 (date) — Date of name change
- Delaware (jurisdiction) — State of incorporation
- Pleasanton, California (location) — Principal executive offices
FAQ
What specific "Other Events" are being reported by AEye, Inc. in this 8-K filing?
The provided text does not detail the specific 'Other Events' beyond listing it as an item information category.
What is the significance of AEye, Inc. formerly being known as CF Finance Acquisition Corp. III?
This indicates a name change occurred on July 17, 2020, suggesting a transition or rebranding from its previous identity.
What is the primary business of AEye, Inc. based on its SIC code?
AEye, Inc.'s SIC code is 3714, which corresponds to 'MOTOR VEHICLE PARTS & ACCESSORIES'.
Where are AEye, Inc.'s principal executive offices located?
AEye, Inc.'s principal executive offices are located at 4670 Willow Road, Suite 125, Pleasanton, California 94588.
What is the filing date and the earliest event date reported in this 8-K?
The filing date and the date of the earliest event reported are both January 23, 2025.
Filing Stats: 659 words · 3 min read · ~2 pages · Grade level 10.2 · Accepted 2025-01-23 06:08:22
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share LIDR The Nasdaq Stock Marke
- $15,291,500 — s Agreement"), to up to an aggregate of $15,291,500 of Placement Shares. The issuance and
Filing Documents
- ss4368921_8k.htm (8-K) — 33KB
- ss4368921_ex0501.htm (EX-5.1) — 16KB
- image_001.jpg (GRAPHIC) — 2KB
- 0000947871-25-000066.txt ( ) — 270KB
- lidr-20250123.xsd (EX-101.SCH) — 4KB
- lidr-20250123_def.xml (EX-101.DEF) — 26KB
- lidr-20250123_lab.xml (EX-101.LAB) — 36KB
- lidr-20250123_pre.xml (EX-101.PRE) — 25KB
- ss4368921_8k_htm.xml (XML) — 6KB
01. Other Events
Item 8.01. Other Events. On January 23, 2025, AEye, Inc. (the "Company") filed the Amendment No. 2 (the "Amendment No. 2") to the Prospectus Supplements (as defined below) to update the maximum number of shares of the Company's common stock (the "Placement Shares") issuable pursuant to the At Market Issuance Sales Agreement between the Company and A.G.P./Alliance Global Partners, dated September 12, 2024 (the "Sales Agreement"), to up to an aggregate of $15,291,500 of Placement Shares. The issuance and sale of the Placement Shares by the Company under the Sales Agreement will be made pursuant to the Company's registration statement on Form S-3 (File No. 333-274546) filed with the Securities and Exchange Commission on September 15, 2023, and declared effective on September 26, 2023, as supplemented and amended by the prospectus supplements, dated as of September 13, 2024 and December 30, 2024 (the "Prospectus Supplements"), the Amendment No. 1 to the Prospectus Supplements, dated as of January 7, 2025, and the Amendment No. 2. A copy of the legal opinion of Allen Overy Shearman Sterling US LLP relating to the Placement Shares is filed as Exhibit 5.1 hereto. This Current Report on Form 8-K shall not constitute an offer to sell or a solicitation of an offer to buy any shares of common stock in any state or jurisdiction in which such an offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.
01. Financial Statement and Exhibits
Item 9.01. Financial Statement and Exhibits. (d) Exhibits. Exhibit Number Description 5.1 Opinion of Allen Overy Shearman Sterling US LLP. 23.1 Consent of Allen Overy Shearman Sterling US LLP (included in Exhibit 5.1). 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AEye, Inc. Dated: January 23, 2025 By: /s/ Andrew S. Hughes Andrew S. Hughes Senior Vice President, General Counsel & Corporate Secretary